Diminished reovirus capsid stability alters disease pathogenesis and littermate transmission

PLoS Pathogens
Joshua D DoyleT S Dermody

Abstract

Reovirus is a nonenveloped mammalian virus that provides a useful model system for studies of viral infections in the young. Following internalization into host cells, the outermost capsid of reovirus virions is removed by endosomal cathepsin proteases. Determinants of capsid disassembly kinetics reside in the viral σ3 protein. However, the contribution of capsid stability to reovirus-induced disease is unknown. In this study, we found that mice inoculated intramuscularly with a serotype 3 reovirus containing σ3-Y354H, a mutation that reduces viral capsid stability, succumbed at a higher rate than those infected with wild-type virus. At early times after inoculation, σ3-Y354H virus reached higher titers than wild-type virus at several sites within the host. Animals inoculated perorally with a serotype 1 reassortant reovirus containing σ3-Y354H developed exaggerated myocarditis accompanied by elaboration of pro-inflammatory cytokines. Surprisingly, unchallenged littermates of mice infected with σ3-Y354H virus displayed higher titers in the intestine, heart, and brain than littermates of mice inoculated with wild-type virus. Together, these findings suggest that diminished capsid stability enhances reovirus replication, dissemina...Continue Reading

References

Dec 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·H L WeinerB N Fields
Jan 1, 1977·Archives of Virology·G HashiroJ T Yau
Jan 1, 1991·Advances in Experimental Medicine and Biology·B S Stein, E G Engleman
May 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·L A MorrisonB N Fields
Oct 1, 1990·Journal of Virology·T S DermodyB N Fields
Nov 1, 1989·Journal of Virology·B SherryB N Fields
Mar 1, 1989·Journal of Virology·D K Bodkin, B N Fields
Feb 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·M ChowD Baltimore
Nov 28, 1970·The Veterinary Record·L Kasza
May 1, 1981·The Journal of General Virology·N KoideG Klein
Aug 19, 1982·The New England Journal of Medicine·R MoreckiM S Horwitz
Jul 1, 1983·The Journal of Infectious Diseases·S J ChanockB N Fields
Dec 1, 1984·The Journal of Pediatrics·J H GlaserR Morecki
Nov 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·M T TostesonB N Fields
May 1, 1994·Journal of Gastroenterology and Hepatology·S C RichardsonA L Smith
Jun 1, 1994·Journal of Virology·N LouisJ Chroboczek

❮ Previous
Next ❯

Methods Mentioned

BETA
xenografts
electrophoresis
ELISA
transfection
fluorescence microscopy

Software Mentioned

Prism
GraphPad
ImageJ

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.